Emerald Health Therapeutics Inc (OTCMKTS:EMHTF) Provides Details About Its Latest Cultivation Expansion License

Emerald Health Therapeutics Inc (OTCMKTS:EMHTF) is pleased to receive the full municipal permitting for its properties in British Columbia. It looks forward to commencing its operations at two of its 78,000 square foot greenhouses. Health Canada has been reviewing the company and after realizing it had met the required conditions gave it the cultivation license amendment.

A close outlook

Emerald is currently staring at an additional license 50,000 square feet growing space, and some other seven grow areas. At the current state of affairs, the business guru can commence its operations at the site. In a statement, the company said it was making plans to kickstart its planting activities at the site. If all moves according to plan, the planting activities may reach completion by the end of Q4.Probably, the first harvest may be in January 2020.

The Chief Executive Officer of Emerald Riaz Bandali has spoken about the matter. He says that they look forward to starting the planting activities. According to the official, the Metro Vancouver organic operation will see the company move to new financial heights.

He also congratulated the company for its most recent achievement. He thinks that the licensing of the Québec premium craft product indoor cultivation site is a major step forward for them. Emerald Health Therapeutics seeks to produce industry-leading products in terms of quality, and it will make it happen in the Metro Vancouver site. The business giant says it will be counting on its extensive experience in production and compliance to make it in the dynamic markets. As always, product consumers in the market aspire to obtain premium organic products, and this is what the company is working towards.

Other major developments

Emerald Health Therapeutics has also spoken about the latest development regarding its wholly-owned production facility, Verdélite. The facility obtained a license amendment permitting from Health Canada. With this development, it seeks to focus on the sale and distribution of packaged, branded dried cannabis products. It will distribute the products to the authorized private retailers and territorial wholesalers. All the products being package by Verdélite are under the Emerald brand.

The other thing is that Emerald Health Therapeutics has distanced itself from certain terms reading its agreement with Pure Sunfarms Corp. It asserts that it doesn’t have any liability in the deal. Pure Sunfarms Corp happens to be Emerald’s 50%-owned joint venture, and the exchanges are in line with the current Supply Agreement between the two. The company is not happy with the way the joint venture conducted the Supply Agreement.

By Steven Russell

Steve covers business and investing in emerging medical marijuana markets. Steve graduated from the university of New Orleans with a degree in Broadcast Journalism. Steve has published several articles in professional journals and magazines. His experience gives readers an inside look at the intersection of his specialties, business and medical marijuana.

Leave a Reply

Your email address will not be published. Required fields are marked *

Emerald Health Therapeutics Inc (OTCMKTS:EMHTF) Posts An Increase Of 340% In Q4 2019 Revenues Emerald Health Therapeutics Inc (OTCMKTS:EMHTF) Announces First Shipment Of Chemdog From Its Richmond Facility: Expects To Receive Orders From Manitoba And Alberta Health Canada Grants Approval For Pure Sunfarms, A JV Of Emerald Health Therapeutics Inc (OTCMKTS:EMHTF), 65,000 Sq. Ft. Processing Center Emerald Health Therapeutics Inc (OTCMKTS:EMHTF) Offers Ultra Pure CBD Oil To The Consumers In British Columbia Emerald Health Therapeutics Inc (CVE:EMH) Expands Cannabis Supply Coverage to Quabec

Pin It on Pinterest